Las tasas en el REEDS: ¿Capitalización de los datos de salud?
DOI:
https://doi.org/10.1387/rdgh.28568Keywords:
datos sanitarios, tasas, acceso, coste, valorAbstract
With the establishment of the European Health Data Space Regulation, the debate arises as to whether access to health information introduces an economic dimension into European digital governance. The broad definition of fees, the lack of harmonised methodological criteria, and national regulatory discretion may lead to asymmetries in access.
Downloads
Published
18-05-2026
How to Cite
Landa, I. (2026). Las tasas en el REEDS: ¿Capitalización de los datos de salud?. Law and the Human Genome Review. Genetics, Biotechnology and Advanced Medicine, 1(62). https://doi.org/10.1387/rdgh.28568
Issue
Section
Articles
License
Copyright (c) 2026 Law and the Human Genome Review. Genetics, Biotechnology and Advanced Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.